Comparison

Biotinylated Human PD-1 / PDCD1 Protein, Fc,Avitag,His Tag European Partner

Item no. PD1-H82F2-200ug
Manufacturer ACROBiosystems
Amount 200 ug
Quantity options 200 ug 25 ug
Category
Type Proteins Recombinant
Format Solid
Specific against Human (Homo sapiens)
Host HEK293
Purity >95% as determined by SDS-PAGE.
Citations (1) Ishida Y., et al., 1992, EMBO J. 11 (11): 3887-95. (2) Blank C., et al., 2007, Cancer Immunol. Immunother. 56 (5): 739-45. (3) Agata Y., et al., 1996, Int. Immunol. 8 (5): 765-72. (4) Freeman GJ., et al., 2000, J. Exp. Med. 192 (7): 1027-34. (5) Latchman Y., et al., 2001, Nat. Immunol. 2 (3): 261-8. (6) Yamazaki T., et al., 2002, J. Immunol. 169 (10): 5538-45.
NCBI NP_005009.2
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias PDCD1,PD1,CD279,SLEB2
Shipping Condition Room temperature
Available
Manufacturer - Category
Protein / Immune Checkpoint Proteins
Shipping Temperature
RT
Storage Conditions
-20°C
Molecular Weight
44.7 kDa
Manufacturer - Format
Powder
Description
Programmed cell death protein 1 (PD-1) is also known as CD279 and PDCD1, is a type I membrane protein and is a member of the extended CD28/CTLA-4 family of T cell regulators. PDCD1 is expressed on the surface of activated T cells, B cells, macrophages, myeloid cells and a subset of thymocytes. PD-1 has two ligands, PD-L1 and PD-L2, which are members of the B7 family. PD-L1 is expressed on almost all murine tumor cell lines, including PA1 myeloma, P815 mastocytoma, and B16 melanoma upon treatment with IFN-gamma. PD-L2 expression is more restricted and is expressed mainly by DCs and a few tumor lines. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-gamma by suppressing the activation and transduction of PI3K/AKT pathway. In addition, coligation of PD1 inhibits BCR-mediating signal by dephosphorylating key signal transducer. In vitro, treatment of anti-CD3 stimulated T cells with PD-L1-Ig results in reduced T cell proliferation and IFN-gamma secretion. Monoclonal antibodies targeting PD-1 that boost the immune system are being developed for the treatment of cancer.
Molecule
PD-1
Exp Region
Leu 25 - Gln 167
Characteristics
This protein carries a human IgG1 Fc fragment at the C-terminus, followed by a polyhistidine tag. The Avi tag (Avitag) is inserted in-between the Fc and his tags. The protein has a calculated MW of 44.7 kDa. The protein migrates as 50-66 kDa on a SDS-PAG
Endotoxin
Less than 1.0 EU per ug by the LAL method.
Buffer
PBS, pH7.4

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close